Regulation of Medicine
Georgia Medical Marijuana Expansion Now in Effect
July 7, 2017
The new medical marijuana law, effective on July 1, 2017, expands the conditions that may be treated by the use of low THC oil. Physicians may now authorize the use of low THC oil for the treatment of:
- Severe Tourette’s syndrome
- Autism spectrum disorder (for patients who are at least 18) or severe autism (for patients under 18)
- Epidermolysis bullosa
- Alzheimer’s disease; when severe or end-stage
- AIDS; when severe or end-stage
- Peripheral neuropathy; when severe or end-stage
The above conditions are in addition to the conditions authorized in 2015, when the law was originally passed, which include:
- End-stage cancer
- Severe or end-stage ALS
- Seizure disorders related to epilepsy or trauma related head injuries
- Severe or end-stage MS
- Crohn’s disease
- Mitochondrial disease
- Severe or end-stage Parkinson’s disease
- Severe or end-stage sickle cell disease
Importantly, physicians are now required to report to the Georgia Medical Board semi-annually, (instead of quarterly), and must now include levels of tetrahydrocannabinol or tetrahydrocannabinolic acid present in test results.
The new law allows patients in hospice care to possess low THC oil. It also allows persons in Georgia for less than 45 days to possess the oil if they possess a registration card issued by another state. It strikes the requirements that individuals must either be a Georgia resident for at least one year, or a child born in Georgia who is less than one year old.
To read the full text of the bill click here.
The information provided in this resource does not constitute legal, medical or any other professional advice, nor does it establish a standard of care. This resource has been created as an aid to you in your practice. The ultimate decision on how to use the information provided rests solely with you, the PolicyOwner.